Navigation Links
Clinical Data for BackBeat Medical's Programmable Hypertension Control Therapy to Be Presented at ICI Meeting 2016
Date:11/29/2016

NEW HOPE, Pa., Nov. 29, 2016 /PRNewswire/ -- BackBeat Medical Inc., a medical technology company developing novel cardiac stimulation-based therapies for hypertension and heart failure, today announced that clinical data for the company's patented Programmable Hypertension Control (PHC) therapy will be presented at the Innovations in Cardiovascular Interventions (ICI) Meeting 2016, Dec. 4-6, in Tel Aviv, Israel.

The presentation will feature results from the first-in-man study of BackBeat's PHC therapy including two years of follow-up data from patients who received BackBeat's Moderato™ pacemaker incorporating the company's proprietary pacing algorithms. Dr. Yuval Mika, CEO and co-founder, will deliver the presentation "Programmable Hypertension Control (PHC) - A Pacemaker-Mediated Novel Approach for the Treatment of Hypertension" during the session "Technology Parade I - Devices" at 9:50 a.m. IST on Monday, Dec. 5 in Room 4 at the David Intercontinental Convention Center.

About BackBeat Medical

BackBeat Medical Inc. is a medical technology company founded in 2010 to develop novel cardiac stimulation-based therapies for hypertension and heart failure. BackBeat has developed a patented cardiac pacing-based treatment for hypertension (HTN) called programmable hypertension control (PHC) therapy. PHC is comprised of proprietary pacing algorithms that can be readily incorporated into standard pacemakers using standard leads and standard lead placement and thus has broad applicability. PHC offers a new potent device-based HTN therapeutic alternative potentially opening up a large market to treat HTN patients, particularly HTN patients who already have or require a pacemaker. Clinical results generated to date using BackBeat's own Moderato™ pacemaker incorporating PHC algorithms demonstrate that this therapy has a substantial and sustained therapeutic effect on blood pressure as determined by both in-office cuff measurements (average reduction of 24 mmHg from baseline) and 24-hour ambulatory measurements (average reduction of 14 mmHg from baseline) with clinical follow up extending up to two years.

Media Contacts:                                                                              

David Schull or Todd Davenport, Ph.D.
Russo Partners, LLC
(212) 845-4271
(212) 845-4235
david.schull@russopartnersllc.com 
todd.davenport@russopartnersllc.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clinical-data-for-backbeat-medicals-programmable-hypertension-control-therapy-to-be-presented-at-ici-meeting-2016-300370035.html


'/>"/>
SOURCE BackBeat Medical Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
2. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
3. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
4. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
5. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
6. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
7. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
8. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
9. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
10. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
11. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... ... April 17, 2019 , ... Knight Security’s patented KnightSentry technology ... Solution tool by Security Today magazine in its annual The Govies Government Security ... in this contest recognizing outstanding government security products. , Knight’s innovative KnightSentry platform ...
(Date:4/17/2019)... ... April 17, 2019 , ... With the US ... Strategies to Expedite Development of Oncology Drugs and Biologics’ – it ... Through years of experience helping sponsors manage complex oncology trials, endpoint ...
(Date:4/17/2019)... ... April 17, 2019 , ... Women’s Excellence in Obstetrics and Gynecology now offers ... concern, you want to be seen by a provider. We believe in getting ... normal routine as soon as possible.” Dr. Jonathan Zaidan, MD, FACOG, President of Women’s ...
Breaking Medicine Technology:
(Date:4/19/2019)... ... , ... It's time to try a better alternative. Why use ... the matter before those pesky dandruff flakes reach your scalp’s surface, making your life ... before it attacks you. New Don’t Flake Me Out Dandruff & Itchy ...
(Date:4/19/2019)... ... April 18, 2019 , ... Edens Garden launches 7 ... deodorants combine the power of 100% pure essential oils and non-toxic ingredients to keep ... only is Edens Garden’s latest product release all-natural but baking soda- and aluminum-free, making ...
(Date:4/19/2019)... ... 19, 2019 , ... The Patient Advocacy Community of The ... Network-CVPH, Plattsburgh, NY with the 2019 Ruth Ravich Patient Advocacy Award in recognition ... patient advocates. Doyle was honored with the award at The Beryl Institute’s annual ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... ability to deliver targeted radiation to cancer cells while sparing surrounding healthy tissue. ... research platforms. Engineered from the ground up for high reliability and ease of ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... energy, concentration, memory, relaxation and restful sleep to support a healthy mind and ... provide mental clarity, focus and vitality. , The portfolio includes a total of ...
Breaking Medicine News(10 mins):